Switching between anti-TNFα agents:: what is the evidence?

被引：19

作者：

Combe, B ^{[1
]}

机构：

[1] Hop Lapeyronie, Serv Immunorhumatol, F-34295 Montpellier 5, France

来源：

JOINT BONE SPINE | 2004年 / 71卷 / 03期

关键词：

Anti-TNF therapy; pharmacokinetis; etanercept; adalimumab; infliximab; treatment switching;

D O I：

10.1016/j.jbspin.2003.10.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：169 / 171

页数：3

共 19 条

[1]

Arend WP, 2002, J RHEUMATOL, V29, P16

[2] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].

Bathon, JM ;

Martin, RW ;

Fleischmann, RM ;

Tesser, JR ;

Schiff, MH ;

Keystone, EC ;

Genovese, MC ;

Wasko, MC ;

Moreland, LW ;

Weaver, AL ;

Markenson, J ;

Finck, BK .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593

[3] Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis [J].

Brandt, J ;

Khariouzov, A ;

Listing, J ;

Haibel, H ;

Sörensen, H ;

Grassnickel, L ;

Rudwaleit, M ;

Sieper, J ;

Braun, J .

ARTHRITIS AND RHEUMATISM, 2003, 48 (06) :1667-1675

[4] Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].

Braun, J ;

Brandt, J ;

Listing, J ;

Zink, A ;

Alten, R ;

Golder, W ;

Gromica-Ihle, E ;

Kellner, H ;

Krause, A ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Thriene, W ;

Sieper, J .

LANCET, 2002, 359 (9313) :1187-1193

[5]

BROCQ L, 1902, ANN DERMATOL SYPHIL, V3, P1

[6]

COHEN JD, 2003, REV RHUM, V70, P996

[7]

Dayer JM, 2002, J RHEUMATOL, V29, P10

[8] REPEATED THERAPY WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

LONGFOX, A ;

CHARLES, P ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1125-1127

[9]

Fleischmann RM, 2002, J RHEUMATOL, V29, P27

[10]

Furst DE, 2003, ANN RHEUM DIS, V62, P2

← 1 2 →